Warning letter
Apollo Care, LLC: warning letter of Feb 2, 2026
FDA warning letter 715955 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 715955 |
|---|---|
| Company | Apollo Care, LLC |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Feb 2, 2026 |
| Posted date | Apr 21, 2026 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 210.1(b), 200.10(b), 211.42(c)(10)(vi), 211.67(a), 211.113(b) |
| Inspection city | Columbia |
| Inspection ZIP | 65202 |
| Inspection start date | Mar 10, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: